Floatz logo

Isotretinoin

Epidermolysis Bullosa

University of North CarolinaSmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Epidermolysis Bullosa cohort.

Asset / SponsorPhaseRating
Oxygen
Jay C. Buckey Jr.
Phase 4BB
Pregabalin
The Hospital for Sick Children
Phase 3B

Same molecule, other indications

Isotretinoin is also rated in:

central nervous system neoplasmDormant
B
Indicative ·
62 / 100
View asset →
brain neoplasmDormant
B
Indicative ·
58 / 100
View asset →
glioblastomaDormant
B
Indicative ·
57 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →